Duality Biotherapeutics, Inc.（09606.HK）股价、图表、新闻与AI分析

Q: DUALITYBIO-B 股票的价格表现如何？

DUALITYBIO-B 的当前价格为 $359，在上个交易日 下降 了 1.04%。

Q: Duality Biotherapeutics, Inc. 的主要业务主题或行业是什么？

Duality Biotherapeutics, Inc. 属于 Biotechnology 行业，该板块是 Health Care

Q: Duality Biotherapeutics, Inc. 的市值是多少？

Duality Biotherapeutics, Inc. 的当前市值是 $31.6B

主页

股票

09606.HK

DUALITYBIO-B (09606.HK)

Duality Biotherapeutics, Inc.

HK$359

-1.04%

$-3.8

休市： Jan 16, 16:00:00 HKT

关键数据

前收盘价

$362.8

开盘价

$362.8

当日区间

$351.8 - $364.8

52周范围

$165.5 - $563.5

交易量

687.0K

平均成交量

1.2M

每股收益（TTM）

-35.81

股息收益率

市值

$31.6B

什么是 DUALITYBIO-B？

Duality Biotherapeutics, Inc. operates as a clinical stage company. The company is headquartered in Shanghai, Shanghai and currently employs 191 full-time employees. The company went IPO on 2025-04-15. The firm is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The firm's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The firm's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The firm principally conducts its businesses in domestic and overseas markets.

功能特性

交易策略